Analyst firms · Morgan Stanley · NVST

Morgan Stanley NVST price target and rating history

Envista Holdings Corporation (NVST) · Health Care

Morgan Stanley rates Envista Holdings Corporation (NVST) Equal-Weight with a $21 price target, as of its latest action on Apr 26, 2024. It has published 4 rating actions on NVST since January 2022, including 1 upgrade and 1 downgrade. Across 5 firms with a NVST price target in the last 12 months, the median target is $27.

Current rating
Equal-Weight
Price target
$21
Median target, all firms
$27
Actions on NVST
4

Morgan Stanley price target on NVST

$52$37$212023202420252026
Morgan Stanley price target on NVST, each point a stated target, January 2022 to April 2024.

Every Morgan Stanley rating on NVST

How other firms rate NVST

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Robert W. BairdNeutral$26Oct 15, 2026
BMO Capital MarketsMarket Perform$27Jul 9, 2026
CitigroupNeutral$29Apr 15, 2026
Leerink PartnersOutperform$35Feb 6, 2026
BarclaysOverweight$24Dec 9, 2025

Questions about Morgan Stanley and NVST

What is Morgan Stanley's price target for NVST?
Morgan Stanley's latest stated price target for Envista Holdings Corporation (NVST) is $21, from its action on Apr 26, 2024.
What is Morgan Stanley's rating on NVST?
Morgan Stanley rates NVST Equal-Weight, a neutral rating, as of Apr 26, 2024.
When did Morgan Stanley last change its view on NVST?
On Apr 26, 2024, Morgan Stanley downgrades to Equal-Weight from Overweight, price target $33 to $21.
How does Morgan Stanley's NVST target compare with other analysts?
Across 5 firms with a NVST price target in the last 12 months, the median target is $27.

More NVST rating histories

All Morgan Stanley ratingsNVST news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.